Conditions Required for the Bactericidal Activity of Fleroxacin and Pefloxacin Against Escherichia Coli KL 16

References

1. Phillips I., King A., Shannon K. In vitro properties of the quinolones. In Andriole V T. ed The quinolones. London: Academic Press; 198883–118
   [Google Scholar]
2. Paganoni R., Herzog C., Braunsteiner A., Hohl P. Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxa-cin. J Antimicrob Chemother 1988; 22: Suppl D 3–17
   [Google Scholar]
3. Gonzalez J P., Henwood J M. Pefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1989; 37:628–668
   [Google Scholar]
4. Smith J T. Awakening the slumbering potential of the 4-quinolone antibacterials. Pharm J 1984; 233:299–305
   [Google Scholar]
5. Smith J T., Lewin C S. Chemistry and mechanisms of action of the quinolone antibacterials. In Andriole V T. ed The quinolones. London: Academic Press; 198823–82
   [Google Scholar]
6. Dietz W H., Cook T M., Goss W A. Mechanism of action of nalidixic acid on Escherichia coli: III. Conditions required for lethality. J Bacteriol 1966; 61:768–773
   [Google Scholar]
7. Lewin C S., Amyes S G B. Bactericidal activity of DR-3355 an optically active isomer of ofloxacin. J Med Microbiol 1989; 30:227–231
   [Google Scholar]
8. Lewin C S., Amyes S G B., Smith J T. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16. Eur J Clin Microbiol Infect Dis 1989; 8:731–733
   [Google Scholar]
9. Ratcliffe N T., Smith J T. Norfloxacin has a novel bactericidal mechanism unrelated to that of other 4- quinolones. J Pharm Pharmacol 1985; 37:92
   [Google Scholar]
10. Zeiler H-J., Grohe K. The in vitro and in vivo activity of ciprofloxacin. Eur J Clin. Microbiol 1984; 3:339–343
    [Google Scholar]
11. Lewin C S., Howard B M., A, Ratcliffe N T., Smith J T. 4-quinolones and the SOS response. J Med Microbiol 1989; 29:139–144
    [Google Scholar]
12. Lewin C S., Smith J T. Bactericidal mechanisms of ofloxacin. J Antimicrob Chemother 1988; 22: Suppl C 1–8
    [Google Scholar]
13. Bergan T. Pharmacokinetics of fluorinated quinolones. In Andriole V T. ed The quinolones. London, Academic Press; 198823–82
    [Google Scholar]
14. Weidekamm E., Portmann R., Partos C., Dell D. Single and multiple dose pharmacokinetics of fleroxacin. J Antimicrob Chemother 1988; 22: Suppl D 145–154
    [Google Scholar]